ConductScience.org, home

Paper7697604

Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer.

Lipton A and 8 others. Cancer, 1995. Cited by 95 papers, by iCite.

Cite this record

ConductScience Library. Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer. Papers, record 7697604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7697604

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer.
PubMed
Journal
Cancer
PubMed
Year
1995
PubMed
Publication types
Clinical Trial, Clinical Trial, Phase I, Journal Article
PubMed
Citations, by iCite
95
iCite
Relative citation ratio, by iCite
3
iCite
Revised in PubMed
2019-06-20
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lipton AA
2Demers LML M
3Harvey HAH A
4Kambic KBK B
5Grossberg HH
6Brady CC
7Adlercruetz HH
8Trunet PFP F
9Santen RJR J

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Aromatase InhibitorsMajor topic
Breast NeoplasmsMajor topic
Neoplasms, Hormone-DependentMajor topic
NitrilesMajor topic
TriazolesMajor topic
Adult
Aged
Estrogen Antagonists
Female
Humans
Letrozole
Middle Aged
Neoplasm Metastasis
Remission Induction

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04421547Efficacy of Letrozole in Recurrent Ovarian CancerBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.

PMIDTitleJournalYearIn PapersSource
42622775History of the early development of aromatase inhibitors for treatment of breast cancer.Breast Cancer Res Treat2026https://conductscience.org/library/papers/42622775PubMed
38983726A comparison of letrozole regimens for ovulation induction in women with polycystic ovary syndrome.F S Rep2024https://conductscience.org/library/papers/38983726PubMed
38911541Steroidogenic cytochrome P450 enzymes as drug target.Toxicol Res2024https://conductscience.org/library/papers/38911541PubMed
37922256Effects of dietary aromatase inhibitors on masculinization of rosy barb (Pethia conchonius): Evidence from growth, coloration and gonado-physiological changes.PLoS One2023https://conductscience.org/library/papers/37922256PubMed
37605693Pregnancy Rates in Women With Polycystic Ovary Syndrome (PCOS) Using Letrozole Versus Clomiphene Citrate: A Retrospective Record Review.Cureus2023https://conductscience.org/library/papers/37605693PubMed
35748065Influence of the anti-oestrogens tamoxifen and letrozole on thyroid function in women with early and advanced breast cancer: A systematic review.Cancer Med2023https://conductscience.org/library/papers/35748065PubMed
32756085Comparison of clomiphene and letrozole for superovulation in patients with unexplained infertility undergoing intrauterine insemination: A systematic review and meta-analysis.Medicine (Baltimore)2020https://conductscience.org/library/papers/32756085PubMed
30851382Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression.J Steroid Biochem Mol Biol2019https://conductscience.org/library/papers/30851382PubMed
29254284Post-menopausal breast cancer: from estrogen to androgen receptor.Oncotarget2017https://conductscience.org/library/papers/29254284PubMed
28854590Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome.Hum Reprod2017https://conductscience.org/library/papers/28854590PubMed
28776988Comprehensive and Automated Linear Interaction Energy Based Binding-Affinity Prediction for Multifarious Cytochrome P450 Aromatase Inhibitors.J Chem Inf Model2017https://conductscience.org/library/papers/28776988PubMed
27091422A MALDI-MS-based quantitative analytical method for endogenous estrone in human breast cancer cells.Sci Rep2016https://conductscience.org/library/papers/27091422PubMed
26667449Double-Blind, Randomized Trial of Alternative Letrozole Dosing Regimens in Postmenopausal Women with Increased Breast Cancer Risk.Cancer Prev Res (Phila)2016https://conductscience.org/library/papers/26667449PubMed
26576332Altered regulation of PDK4 expression promotes antiestrogen resistance in human breast cancer cells.Springerplus2015https://conductscience.org/library/papers/26576332PubMed
23997058Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models.Eur Respir Rev2013https://conductscience.org/library/papers/23997058PubMed
23927370Molecular simulations of aromatase reveal new insights into the mechanism of ligand binding.J Chem Inf Model2013https://conductscience.org/library/papers/23927370PubMed
22006184Estrogen receptor-beta mediates the protective effects of aromatase induction in the MMTV-Her-2/neu x aromatase double transgenic mice.Horm Cancer2012https://conductscience.org/library/papers/22006184PubMed
21681442Insight into the binding interactions of CYP450 aromatase inhibitors with their target enzyme: a combined molecular docking and molecular dynamics study.J Mol Model2012https://conductscience.org/library/papers/21681442PubMed
21494765Population pharmacokinetic analysis of letrozole in Japanese postmenopausal women.Eur J Clin Pharmacol2011https://conductscience.org/library/papers/21494765PubMed
21385795Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study.Oncologist2011https://conductscience.org/library/papers/21385795PubMed

See all 33 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CYP19A11588PubTator's text mininghttps://conductscience.org/library/genes/1588

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7697604

GET https://conductscience.org/api/papers/v1/7697604/cited_by?page=2